News
EndoPredict Breast Cancer Prognostic Test
Second generation gene expression test for FFPE tumor tissue.
21/02/2025
The 2024 Emissions Report
As part of our commitment to sustainability, we partner with DHL to cut transport related emissions. Details available in our new 2024 Emissions Report!
19/02/2025
New Brand to reflect growth, innovation, and a unified vision to become a leading global Specialty Diagnostics company
We are happy to announce that Eurobio Scientific UK will undertake a brand update to align with the evolving structure of the Eurobio Scientific Group.
This new brand embodies the collective strengths of all our affiliates, combining expertise and resources to create synergies to enhance our product offerings.
12/11/2024
Navigating ER+ HER2- Early Breast Cancer
November 19, 2024 - Join us for the first seminar in our new series!
“Navigating ER+ HER2- Early Breast Cancer”
The session “What's new for high-risk early breast cancer patients” will focus on CDK4/6 inhibitors in the adjuvant setting for high-risk breast cancer patients, featuring a real-life case discussion and insights into the potential role of gene expression tests, including prospective validation data in high- risk patients (UNIRAD).
07/11/2024
New Distribution Partnership with UTAK for Toxicology Quality Control Solutions
Eurobio Scientific UK is thrilled to announce its new partnership with UTAK, an esteemed American company specialising in Toxicology quality control solutions.
19/11/2023
BioGX Candida Auris PCR Assay Global Adoption Accelerates
BioGX, a global provider of easy molecular diagnostic solutions, announced accelerated adoption of their high performance Sample-Ready PCR assay for detection of Candida auris, a rapidly spreading, hard to treat fungus with a growing presence in hospitals and long-term care facilities.
24/07/2023
New Partnership With Vela Diagnostics
Vela Diagnostics, a manufacturer of NGS and PCR workflows based in Germany, has partnered with Eurobio Scientific UK; in an exclusive agreement to distribute and represent its products in the UK and Ireland.
In the UK and Ireland, Eurobio Scientific UK will support its existing customers, its equipment and workflow, also delivering 1st line support.
14/07/2023
New proprietary test for the diagnosis of Monkeypox
The EBX 060 Eurobioplex Monkeypox Screening Test (hMPXV, VZV, Measles) is developed specifically for routine screening of simian pox, varicella and measles viruses.
27/06/2022
Maelstrom 9610
Maelstrom 9610 is an automated nucleic acid platform designed for high-throughput applications. Specialized spin tips enable efficient mixing of magnetic beads with a larger processing volume. With an intuitive user interface and flexible programming, Maelstrom 9610 can boost laboratory productivity by transforming routine operations into a walk-away solution.
17/05/2022
EurobioPlex EBX-047 SARS-CoV-2Fast-SVD
Real time RT-PCR for qualitative detection1 of SARS-COV-2 and its VOCs
18/03/2022
New Partnership - Haematex
Developing and providing better laboratory methods for investigating blood clotting and bleeding disorders.
18/03/2022
New test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2
Eurobio Scientific launches new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2
09/03/2022